Rebeccamycin derivative containing pharmaceutical composition
    1.
    发明授权
    Rebeccamycin derivative containing pharmaceutical composition 失效
    含贝贝卡霉素衍生物的药物组合物

    公开(公告)号:US4808613A

    公开(公告)日:1989-02-28

    申请号:US169785

    申请日:1988-03-18

    IPC分类号: C07H19/044 A61K31/40

    CPC分类号: C07H19/044

    摘要: There are disclosed analogs of the antitumor agent, rebaccamycin, which possess antineoplastic properties against mammalian, particularly experimental animal, tumor systems. The compounds of the invention are aminoalkylated derivatives of rebeccamycin produced by first reacting rebeccamycin with a strong base to obtain a reactive intermediate and then reacting the reactive intermediate with an aminoalkyl compound.

    摘要翻译: 公开了具有针对哺乳动物,特别是实验动物肿瘤系统的抗肿瘤特性的抗肿瘤剂,雷卡霉素类似物。 本发明化合物是通过首先使雷贝卡霉素与强碱反应得到反应性中间体,然后使反应性中间体与氨基烷基化合物反应而制备的雷贝卡霉素的氨基烷基化衍生物。

    Rebeccamycin analogs
    2.
    发明授权
    Rebeccamycin analogs 失效
    雷贝卡霉素类似物

    公开(公告)号:US4785085A

    公开(公告)日:1988-11-15

    申请号:US933428

    申请日:1986-11-21

    CPC分类号: C07H19/044

    摘要: There are disclosed analogs of the antitumor agent, rebeccamycin, which possess antineoplastic properties against mammalian, particularly experimental animal, tumor systems. The compounds of the invention are aminoalkylated derivatives of rebeccamycin produced by first reacting rebeccamycin with a strong base to obtain a reactive intermediate and then reacting the reactive intermediate with an aminoalkyl compound.

    摘要翻译: 公开了具有针对哺乳动物特别是实验动物肿瘤系统的抗肿瘤特性的抗肿瘤剂雷贝卡霉素类似物。 本发明化合物是通过首先使雷贝卡霉素与强碱反应得到反应性中间体,然后使反应性中间体与氨基烷基化合物反应而制备的雷贝卡霉素的氨基烷基化衍生物。